atorvastatin + citalopram

Atorvastatin + citalopram is a combination of two small-molecule pharmaceutical drugs, each with distinct mechanisms of action and primary indications. Atorvastatin is an HMG-CoA reductase inhibitor (statin) used to lower cholesterol and prevent cardiovascular events by inhibiting the enzyme responsible for cholesterol synthesis in the liver. Citalopram is a selective serotonin reuptake inhibitor (SSRI) antidepressant that increases serotonergic activity in the central nervous system by inhibiting serotonin reuptake, primarily used to treat major depressive disorder and other mood disorders. There are no known clinically significant pharmacokinetic or pharmacodynamic interactions between these two agents, and they are considered safe for co-administration[1][2][4]. Recent observational studies suggest that concurrent use may improve adherence to antidepressant therapy without affecting depressive symptoms[6].